Peter S. Sever

Overview

Best Publications

• Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

  Marc S. Sabatine;Robert P. Giugliano;Anthony C. Keech;Narimon Honarpour

  5551
  Citations

• Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

  Peter S Sever;Björn Dahlöf;Neil R Poulter;Hans Wedel

  4662
  Citations

• Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

  Björn Dahlöf;Peter S Sever;Neil R Poulter;Hans Wedel

  3434
  Citations

• Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.

  Peter M Rothwell;Sally C Howard;Eamon Dolan;Eoin O'Brien

  2330
  Citations

• Defining the role of common variation in the genomic and biological architecture of adult human height

  Andrew R. Wood;Tonu Esko;Jian Yang;Sailaja Vedantam

  2210
  Citations

• Interpretation of the evidence for the efficacy and safety of statin therapy.

  Rory Collins;Christina Reith;Jonathan Emberson;Jane Armitage

  1854
  Citations

• Genetic studies of body mass index yield new insights for obesity biology

  Adam E. Locke;Bratati Kahali;Sonja I. Berndt;Anne E. Justice

  1689
  Citations

• Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits.

  Evangelos Evangelou;Evangelos Evangelou;Helen R. Warren;Helen R. Warren;David Mosen-Ansorena;Borbala Mifsud

  1472
  Citations

• Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV

  Williams B;Poulter Nr;Brown Mj;Davis M

  1465
  Citations

• Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries

  Mary F. Feitosa;Aldi T. Kraja;Daniel I. Chasman;Yun J. Sung

  1170
  Citations

• Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

  Bryan Williams;Thomas M MacDonald;Steve Morant;David J Webb

  1094
  Citations

• British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

  Bryan Williams;Neil R Poulter;Morris J Brown;Mark Davis

  1083
  Citations

• Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke

  Peter M Rothwell;Sally C Howard;Eamon Dolan;Eoin O'Brien

  853
  Citations

• Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial

  Peter S Sever;Björn Dahlöf;Neil R Poulter;Hans Wedel

  805
  Citations

• HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

  Daniel I Swerdlow;David Preiss;Karoline B Kuchenbaecker;Michael Holmes

  803
  Citations

• Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension

  Neil Chapman;Joanna Dobson;Sarah Wilson;Björn Dahlöf

  792
  Citations

• Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.

  Michelle L. O’Donoghue;Sergio Fazio;Robert P. Giugliano;Erik S.G. Stroes

  754
  Citations

• Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

  Marc P. Bonaca;Patrice Nault;Robert P. Giugliano;Anthony C. Keech

  750
  Citations

• Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials

  Jessica L Mega;Nathan O Stitziel;J Gustav Smith;J Gustav Smith;Daniel I Chasman

  705
  Citations

• Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits

  Evangelos Evangelou;Helen R. Warren;David Mosen-Ansorena;Borbala Mifsu

  0
  Citations